Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
Paused · Phase 1/Phase 2
Conditions studied: Lung Disease
In brief
Chronic Obstructive Pulmonary Disease (COPD) is a lung-related disorder that is characterized by long-term, often progressive state of poor airflow. Primary symptoms include low oxygen tension, shortness of breath, productive cough, and broncho-pulmonary inflammation and interference with oxygen-carbon dioxide exchange. Air pollution and tobacco smoking are felt to be the most common cause of these issues. Diagnostic testing is based on poor airflow measured by lung function studies and whose symptoms do not improve much with antiasthma bronchodilators. Study is an interventional study to document the safety and efficacy of use of AD-cSVF in chronic broncho-pulmonary disease groups.
Key facts
- Study ID
- NCT02946658
- Run by
- Healeon Medical Inc
- People needed
- 100
- Starts
- 2016-10-01
- Expected to finish
- 2027-08-14
- Last updated by the study team
- 2025-09-12
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Prior Diagnosis of moderate to severe COPD
- GOLD II a, III, IV
You may not qualify if…
- Pregnant or Lactating Females
- Life expectancy of < 3 months due to concomitant illnesses
- Exposure to any investigational drug or procedure with 1 month prior to study entry or enrollment in concurrent study which may interfere with interpretation of study results
- Illness which, in investigators judgement, may interfere with the patient' ability to comply with protocol, compromise patient safety, ability to provide informed consent to study, or interfere with interpretation of study outcomes
- Subjects on chronic immunosuppressive or chemotherapeutic medications
- Known drug or alcohol dependence or other factors which may interfere with study conduct or interpretation of result or in the opinion of investigator are not suitable to participate.
- Subjects with documented Alpha-1 Antitrypsin Deficiency (Inherited lung and liver disorder)
- Unwilling or not competent to understand and execute an informed consent agreement
- Patients positive for Hepatitis (Hepatitis A history excepted)
Where it is running
- Regenevita LLC — Stevensville, Montana, United States
- Global Alliance for Regenerative Medicine (GARM) — Roatán, HN, Honduras
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.